Clinical success of anti-infective combination therapy compare to monotherapy in patients with carbapenem-resistant Pseudomonas aeruginosa infection: a 10-years retrospective study.

Publication Year: 2024

DOI:
10.1186/s12879-024-09060-2

PMCID:
PMC10885531

PMID:
38395760

Journal Information

Full Title: BMC Infect Dis

Abbreviation: BMC Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThis project was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center (Boston, MA, USA) and the Massachusetts Institute of Technology (Cambridge, MA, USA). The collection of patient information and creation of the research resource was reviewed by the Institutional Review Board at the Beth Israel Deaconess Medical Center, who granted a waiver of informed consent and approved the data sharing initiative. The study authors had complete the CITI Program course (Human Research and Data or Specimens Only Research) to gain access to the database (Record ID: 47755805). The information of patients in this study is deidentified and anonymous. Individual permission was not required for this retrospective analysis. All methods were performed in accordance with the relevant guidelines and regulations. We have currently gone through the course to obtain permission from the ethics committee mentioned above to obtain information of deidentified patients from the database, not from the authors' hospital, so this study may only require approval from the committee above, not the the ethics committee affiliated to authors. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding Not applicable."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025